In March of this year, the Washington State Legislature passed Senate Bill 5693. Section 211, subpart 99 of this bill directs the Washington State Health Care Authority (HCA) to create a psilocybin work group to assess the feasibility of bills like Senate Bill 5660 (see our initial take on that one here). In particular, the
On September 6, 2022, the San Francisco Board of Supervisors unanimously voted to pass a resolution aimed at decriminalizing psychedelics. This is yet another victory in the battle against prohibition. But it’s important to remember that decriminalization is very different from legalization– just see my older summary of a host of decriminalization efforts. Decriminalization does
This will be one of the most important weeks for Oregon psilocybin to date, at least from a news and public information perspective. This is because we expect the Oregon Health Authority (OHA) to publish all remaining proposed administrative rules for the Oregon psilocybin program. The forthcoming rules should cover everything outlined in Measure 109
In 2023, Oregon will have a regulated psilocybin market. Colorado voters will have a chance to vote on something similar this fall (although Initiative 58 would not take effect until 2024). Other than that, not a single other state has any form of psychedelic regulation in the works. Last week, an attempt to simply decriminalize
Jamaica is establishing itself as a global psilocybin leader. It surprises many people to learn that psilocybin has never been prohibited in the Caribbean nation and is not one of the controlled substances listed in Jamaica’s Dangerous Drugs Act. Over the past few years, we’ve fielded a number of inquiries in and around prospective and
In 2021, California State Senator Scott Wiener introduced SB-519, a statewide psychedelics decriminalization bill. Senator Wiener didn’t have the support to push the bill all the way forward in 2021, so he gathered momentum for a 2022 vote. After a gutting by the California Assembly, the state won’t decriminalize psychedelics in 2022. I’ve regularly blogged on
A recently published letter (“Letter”) indicates that the Biden administration is preparing for the approval of psychedelic drugs and MDMA to treat mental illness and PTSD. This type of federal agency correspondence would have been unimaginable five or six years ago. Things are changing fast! There are well-known potential health benefits of MDMA and psychedelics
Friday was a great day for psychedelics. More generally, Friday was a great day for science and medicine, the rule of law and rational inquiry. This is because the DEA backed down on its clumsy attempt to ban five more psychedelic substances (tryptamines), which it had moved to place on Schedule I of the federal
A statewide psychedelics decriminalization bill that’s been on pause for almost a year was recently set for a legislative hearing next month. This is huge news for California psychedelics advocates, even if we don’t have a ton of information on what is likely to happen just yet. In 2021, California State Senator Scott Wiener introduced
Since January 1, 2021, the Oregon Health Authority (OHA) has engaged in a two-year development phase, creating regulations based on Ballot Measure 109. There are five subcommittees covering different aspects of the emerging psilocybin industry including research, health equity, manufacturing, training, and licensing. In this post, we will cover the most recent Research Subcommittee meeting
